Phenylketonuria

The Lancet

Volumn 376, Issue 9750, 2010, Pages 1417-1427

  Blau, Nenad ^a,b   Van Spronsen, Francjan J ^c   Levy, Harvey L ^d  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BIOPTERIN; GLYCOPROTEIN; NEOPTERIN; PHENYLALANINE; PHENYLALANINE 4 MONOOXYGENASE; PHENYLALANINE AMMONIA LYASE; TETRAHYDROBIOPTERIN;

AMINO ACID METABOLISM; AUTOSOMAL RECESSIVE INHERITANCE; BLOOD ANALYSIS; BLOOD BRAIN BARRIER; BLOOD SAMPLING; CLINICAL ASSESSMENT; COGNITIVE DEFECT; CONFERENCE PAPER; DIET RESTRICTION; DIET THERAPY; DISEASE CLASSIFICATION; ENZYME ACTIVITY; ENZYME THERAPY; EXON; GENE MUTATION; GENE THERAPY; HUMAN; HYPERPHENYLALANINEMIA; INBORN ERROR OF METABOLISM; MATERNAL BLOOD; MENTAL DEFICIENCY; MENTAL FUNCTION; MICROCEPHALY; MOLECULAR GENETICS; NEWBORN SCREENING; PATHOPHYSIOLOGY; PHENOTYPE; PHENYLKETONURIA; PREVALENCE; PRIORITY JOURNAL; COMPLICATION; FEMALE; INTELLECTUAL DISABILITY; NEWBORN; PHENYLKETONURIAS; PREGNANCY; PREGNANCY COMPLICATION;

FEMALE; HUMANS; INFANT, NEWBORN; INTELLECTUAL DISABILITY; NEONATAL SCREENING; PHENYLKETONURIAS; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 78049297042     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)60961-0     Document Type: Conference Paper

References (103)

1. CR Scriver, S Kaufman Hyperphenylalaninemia: phenylalanine hydroxylase deficiency CR Scriver AL Beaudet WS Sly D Valle B Childs B Vogelstein The metabolic and molecular bases of inherited disease 8th edn. 2001 McGraw-Hill New York 1667 1724
2. A Fölling Über Ausscheidung von Phenylbrenztraubensäure in den Harn als Stoffwechselanomalie in Verbindung mit Inbicillität Ztschr Physiol Chem 227 1934 169
3. H Bickel, JW Gerrard, EM Hickmans Influence of phenylalanine intake on phenylketonuria Lancet 2 1953 812 819
4. R Guthrie, A Susi A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants Pediatrics 32 1963 338 343
5. JH Walter, FJ White, SK Hall How practical are recommendations for dietary control in phenylketonuria? Lancet 360 2002 55 57
6. JG Loeber Neonatal screening in Europe; the situation in 2004 J Inherit Metab Dis 30 2007 430 438
7. I Ozalp, T Coskun, A Tokatli Newborn PKU screening in Turkey: at present and organization for future Turk J Pediatr 43 2001 97 101
8. J Zschocke, JP Mallory, HG Eiken, NC Nevin Phenylketonuria and the peoples of Northern Ireland Hum Genet 100 1997 189 194
9. P Guldberg, KF Henriksen, I Sipila, F Guttler, A de la Chapelle Phenylketonuria in a low incidence population: molecular characterisation of mutations in Finland J Med Genet 32 1995 976 978
10. National institutes of health consensus development panel National institutes of health consensus development conference statement: phenylketonuria: screening and management, October 16-18, 2000 Pediatrics 108 2001 972 982
11. GJ Borrajo Newborn screening in Latin America at the beginning of the 21st century J Inherit Metab Dis 30 2007 466 481
12. JY Zhan, YF Qin, ZY Zhao Neonatal screening for congenital hypothyroidism and phenylketonuria in China World J Pediatr 5 2009 136 139
13. J Jiang, X Ma, X Huang A survey for the incidence of phenylketonuria in Guangdong, China Southeast Asian J Trop Med Public Health 34 Suppl 3 2003 185
14. S Pangkanon, W Charoensiriwatana, N Janejai, W Boonwanich, S Chaisomchit Detection of phenylketonuria by the newborn screening program in Thailand Southeast Asian J Trop Med Public Health 40 2009 525 529
15. K Aoki, M Ohwada, T Kitagawa Long-term follow-up study of patients with phenylketonuria detected by the newborn screening programme in Japan J Inherit Metab Dis 30 2007 608
16. Phenylketonuria (PKU): screening and management NIH Consens Statement. October 16-18, 2000; 17: 1-33 http://consensus.nih.gov/2000/ 2000Phenylketonuria113PDF.pdf (accessed Feb 10, 2010).
17. LR Desviat, B Perez, A Gamez Genetic and phenotypic aspects of phenylalanine hydroxylase deficiency in Spain: molecular survey by regions Eur J Hum Genet 7 1999 386 392
18. SL Woo, AS Lidsky, F Guttler, T Chandra, KJ Robson Cloned human phenylalanine hydroxylase gene allows prenatal diagnosis and carrier detection of classical phenylketonuria Nature 306 1983 151 155
19. CR Scriver The PAH gene, phenylketonuria, and a paradigm shift Hum Mutat 28 2007 831 845
20. J Zschocke Phenylketonuria mutations in Europe Hum Mutat 21 2003 345 356
21. M Lindner Treatment of phenylketonuria variants: European recommendations N Blau PKU and BH4: advances in phenylketonuria and tetrahydrobiopterin 2006 SPS Verlagsgesellschaft mbH Heilbronn 180 187
22. F Güttler Hyperphenylalaninemia diagnosis and classification of the various types of phenylalanie hydroxylase deficiency in childhood Acta Pediat Scand 280 1980 1 80
23. B Thöny, N Blau Mutations in the BH4-metabolizing genes GTP cyclohydroalse I, 6-pyruvoyl-tetrahydropterin synthase, sepiapterin reductase, carbinolamine-4a-dehydratase, and dihydropteridine reductase genes Hum Mutat 27 2006 870 878
24. N Blau, B Thöny, RGH Cotton, K Hyland Disorders of tetrahydrobiopterin and related biogenic amines CR Scriver AL Beaudet WS Sly D Valle B Childs B Vogelstein The metabolic and molecular bases of inherited disease 8th edn. 2001 McGraw-Hill New York 1725 1776
25. H Ichinose, T Ohye, E Takahashi Hereditary progressive dystonia with marked diurnal fluctuation caused by mutation in the GTP cyclohydrolase I gene Nat Genet 8 1994 236 241
26. L Bonafé, B Thöny, JM Penzien, B Czarnecki, N Blau Mutations in the sepiapterin reductase gene cause a novel tetrahydrobiopterin-dependent monoamine neurotransmitter deficiency without hyperphenylalaninemia Am J Hum Genet 69 2001 269 277
27. R Surtees, N Blau Neurochemistry of phenylketonuria Eur J Pediatr 159 2000 109 113
28. KD Pearsen, AD Gean-Marton, HL Levy, KR Davis Phenylketonuria: MR imaging of the brain with clinical correlation Radiology 177 1990 437 440
29. PJ Anderson, SJ Wood, DE Francis, L Coleman, V Anderson, A Boneh Are neuropsychological impairments in children with early-treated phenylketonuria (PKU) related to white matter abnormalities or elevated phenylalanine levels? Dev Neuropsychol 32 2007 645 668
30. J Pietz, R Kreis, A Rupp Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria J Clin Invest 103 1999 1169 1178
31. M Hoeksma, DJ Reijngoud, J Pruim, HW de Valk, AM Paans, FJ van Spronsen Phenylketonuria: high plasma phenylalanine decreases cerebral protein synthesis Mol Genet Metab 96 2009 177 182
32. F Horster, MA Schwab, SW Sauer Phenylalanine reduces synaptic density in mixed cortical cultures from mice Pediatr Res 59 2006 544 548
33. AE Martynyuk, AV Glushakov, C Sumners, PJ Laipis, DM Dennis, CN Seubert Impaired glutamatergic synaptic transmission in the PKU brain Mol Genet Metab 86 suppl 1 2005 34 42
34. S Shefer, GS Tint, D Jean-Guillaume Is there a relationship between 3-hydroxy-3-methylglutaryl coenzyme a reductase activity and forebrain pathology in the PKU mouse? J Neurosci Res 61 2000 549 563
35. A Ghozlan, O Varoquaux, V Abadie Is monoamine oxydase-B a modifying gene and phenylethylamine a harmful compound in phenylketonuria? Mol Genet Metab 83 2004 337 340
36. JJ Moyle, AM Fox, M Arthur, M Bynevelt, JR Burnett Meta-analysis of neuropsychological symptoms of adolescents and adults with PKU Neuropsychol Rev 17 2007 91 101
37. SE Waisbren, K Noel, K Fahrbach Phenylalanine blood levels and clinical outcomes in phenylketonuria: a systematic literature review and meta-analysis Mol Genet Metab 92 2007 63 70
38. I Smith, MG Beasley, AE Ades Intelligence and quality of dietary treatment in phenylketonuria Arch Dis Child 65 1990 472 478
39. KH VanZutphen, W Packman, L Sporri Executive functioning in children and adolescents with phenylketonuria Clin Genet 72 2007 13 18
40. V Leuzzi, M Pansini, E Sechi Executive function impairment in early-treated PKU subjects with normal mental development J Inherit Metab Dis 27 2004 115 125
41. A Diamond, MB Prevor, G Callender, DP Druin Prefrontal cortex cognitive deficits in children treated early and continuously for PKU Monogr Soc Res Child Dev 62 1997 1 208
42. J Albrecht, SF Garbade, P Burgard Neuropsychological speed tests and blood phenylalanine levels in patients with phenylketonuria: a meta-analysis Neurosci Biobehav Rev 33 2009 414 421
43. SC Huijbregts, LM de Sonneville, R Licht, FJ van Spronsen, PH Verkerk, JA Sergeant Sustained attention and inhibition of cognitive interference in treated phenylketonuria: associations with concurrent and lifetime phenylalanine concentrations Neuropsychologia 40 2002 7 15
44. GL Arnold, BM Kramer, RS Kirby Factors affecting cognitive, motor, behavioral and executive functioning in children with phenylketonuria Acta Paediatr 87 1998 565 570
45. DA White, MJ Nortz, T Mandernach, K Huntington, RD Steiner Age-related working memory impairments in children with prefrontal dysfunction associated with phenylketonuria J Int Neuropsychol Soc 8 2002 1 11
46. KM Antshel, SE Waisbren Developmental timing of exposure to elevated levels of phenylalanine is associated with ADHD symptom expression J Abnorm Child Psychol 31 2003 565 574
47. J Pietz, B Fatkenheuer, P Burgard, M Armbruster, G Esser, H Schmidt Psychiatric disorders in adult patients with early-treated phenylketonuria Pediatrics 99 1997 345 350
48. S Baieli, L Pavone, C Meli, A Fiumara, M Coleman Autism and phenylketonuria J Autism Dev Disord 33 2003 201 204
49. SE Waisbren, HL Levy Agoraphobia in phenylketonuria J Inherit Metab Dis 14 1991 755 764
50. SE Waisbren, J Zaff Personality disorder in young women with treated phenylketonuria J Inherit Metab Dis 17 1994 584 592
51. J Weglage, B Funders, B Wilken Psychological and social findings in adolescents with phenylketonuria Eur J Pediatr 151 1992 522 525
52. R Gassio, R Artuch, MA Vilaseca Cognitive functions in classic phenylketonuria and mild hyperphenylalaninaemia: experience in a paediatric population Dev Med Child Neurol 47 2005 443 448
53. S Channon, G Goodman, S Zlotowitz, C Mockler, PJ Lee Effects of dietary management of phenylketonuria on long-term cognitive outcome Arch Dis Child 92 2007 213 218
54. AM Bosch, W Tybout, FJ van Spronsen, HW de Valk, FA Wijburg, MA Grootenhuis The course of life and quality of life of early and continuously treated Dutch patients with phenylketonuria J Inherit Metab Dis 30 2007 29 34
55. E Simon, M Schwarz, J Roos Evaluation of quality of life and description of the sociodemographic state in adolescent and young adult patients with phenylketonuria (PKU) Health Qual Life Outcomes 6 2008 25
56. V Anastasoaie, L Kurzius, P Forbes, S Waisbren Stability of blood phenylalanine levels and IQ in children with phenylketonuria Mol Genet Metab 95 2008 17 20
57. A Mazur, S Jarochowicz, J Sykut-Cegielska, W Gradowska, A Kwolek, M Oltarzewski Evaluation of somatic development in adult patients with previously undiagnosed and/or untreated phenylketonuria Med Princ Pract 19 2010 46 50
58. R Gassio, J Campistol, MA Vilaseca, N Lambruschini, FJ Cambra, E Fuste Do adult patients with phenylketonuria improve their quality of life after introduction/resumption of a phenylalanine-restricted diet? Acta Paediatr 92 2003 1474 1478
59. PJ Lee, A Amos, L Robertson Adults with late diagnosed PKU and severe challenging behaviour: a randomised placebo-controlled trial of a phenylalanine-restricted diet J Neurol Neurosurg Psychiatry 80 2009 631 635
60. R Koch, R Moats, F Guttler, P Guldberg, M Nelson Jr. Blood-brain phenylalanine relationships in persons with phenylketonuria Pediatrics 106 2000 1093 1096
61. RR Lenke, HL Levy Maternal phenylketonuria and hyperphenylalaninemia: an international survey of the outcome of untreated and treated pregnancies N Engl J Med 303 1980 1202 1208
62. KF Widaman, C Azen Relation of prenatal phenylalanine exposure to infant and childhood cognitive outcomes: results from the international maternal PKU collaborative study Pediatrics 112 2003 1537 1543
63. F Maillot, M Lilburn, J Baudin, DW Morley, PJ Lee Factors influencing outcomes in the offspring of mothers with phenylketonuria during pregnancy: the importance of variation in maternal blood phenylalanine Am J Clin Nutr 88 2008 700 705
64. R Koch, W Hanley, H Levy The maternal phenylketonuria international study: 1984-2002 Pediatrics 112 2003 1523 1529
65. N Blau, A Belanger-Quintana, M Demirkol Management of phenylketonuria in Europe: survey results from 19 countries Mol Genet Metab 99 2010 109 115
66. N Blau, L Bonafé, M Blaskovics Disorders of phenylalanine and tetrahydrobiopterin metabolism N Blau M Duran M Blaskovics KM Gibson Physicians' guide to the laboratory diagnosis of metabolic disease 2005 Springer Heidelberg 89 106
67. H Levy, B Burton, S Cederbaum, C Scriver Recommendations for evaluation of responsiveness to tetrahydrobiopterin (BH(4)) in phenylketonuria and its use in treatment Mol Genet Metab 92 2007 287 291
68. N Blau, A Belanger-Quintana, M Demirkol Optimizing the use of sapropterin (BH4) in the management of phenylketonuria Mol Genet Metab 96 2009 158 163
69. N Blau Defining tetrahydrobiopterin (BH4)-responsiveness in PKU J Inherit Metab Dis 31 2008 2 3
70. C Bernegger, N Blau High frequency of tetrahydrobiopterin-responsiveness among hyperphenylalaninemias: A study of 1919 patients observed from 1988 to 2002 Mol Genet Metab 77 2002 304 313
71. National institutes of health (NIH) to host a consensus development conference on screening and management for phenylketonuria (PKU) Pediatr Nurs 26 2000 539
72. FJ van Spronsen, KK Ahring, M Gizewska PKU-what is daily practice in various centres in Europe? Data from a questionnaire by the scientific advisory committee of the European society of phenylketonuria and allied disorders J Inherit Metab Dis 32 2009 58 64
73. JH Walter, FJ White Blood phenylalanine control in adolescents with phenylketonuria Int J Adolesc Med Health 16 2004 41 45
74. MR Crone, FJ van Spronsen, K Oudshoorn, J Bekhof, G van Rijn, PH Verkerk Behavioural factors related to metabolic control in patients with phenylketonuria J Inherit Metab Dis 28 2005 627 637
75. GM Olsson, SM Montgomery, J Alm Family conditions and dietary control in phenylketonuria J Inherit Metab Dis 30 2007 708 715
76. J Bekhof, FJ van Spronsen, MR Crone, M van Rijn, CG Oudshoorn, PH Verkerk Influence of knowledge of the disease on metabolic control in phenylketonuria Eur J Pediatr 162 2003 440 442
77. CE Laclair, DM Ney, EL MacLeod, MR Etzel Purification and use of glycomacropeptide for nutritional management of phenylketonuria J Food Sci 74 2009 E199 E206
78. DM Ney, ST Gleason, SC van Calcar Nutritional management of PKU with glycomacropeptide from cheese whey J Inherit Metab Dis 32 2009 32 39
79. K Lim, SC van Calcar, KL Nelson, ST Gleason, DM Ney Acceptable low-phenylalanine foods and beverages can be made with glycomacropeptide from cheese whey for individuals with PKU Mol Genet Metab 92 2007 176 178
80. SC van Calcar, EL MacLeod, ST Gleason Improved nutritional management of phenylketonuria by using a diet containing glycomacropeptide compared with amino acids Am J Clin Nutr 89 2009 1068 1077
81. MR Zurflüh, J Zschocke, M Lindner Molecular genetics of tetrahydrobiopterin responsive phenylalanine hydroxylase deficiency Hum Mutat 29 2008 167 175
82. S Kure, DC Hou, T Ohura Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency J Pediatr 135 1999 375 378
83. E Kayaalp, E Treacy, PJ Waters, S Byck, P Nowacki, CR Scriver Human phenylalanine hydroxylase mutations and hyperphenylalaninemia phenotypes: a meta-analysis of genotype-phenotype correlations Am J Hum Genet 61 1997 1309 1317
84. I Karacic, D Meili, V Sarnavka Genotype-predicted tetrahydrobiopterin (BH4)-responsiveness and molecular genetics in Croatian patients with phenylalanine hydroxylase (PAH) deficiency Mol Genet Metab 97 2009 165 171
85. N Blau, H Erlandsen The metabolic and molecular bases of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency Mol Genet Metab 82 2004 101 111
86. AL Pey, A Martinez The activity of wild-type and mutant phenylalanine hydroxylase and its regulation by phenylalanine and tetrahydrobiopterin at physiological and pathological concentrations: an isothermal titration calorimetry study Mol Genet Metab 86 suppl 1 2005 43 53
87. SW Gersting, KF Kemter, M Staudigl Loss of function in phenylketonuria is caused by impaired molecular motions and conformational instability Am J Hum Genet 83 2008 5 17
88. L Levy, A Milanowski, A Chakrapani Efficacy of sapropterin dihydrochloride (tetrahydrobiopterin, 6R-BH4) for reduction of phenylalanine concentration in patients with phenylketonuria: a phase III randomized placebo-controlled study Lancet 370 2007 504 510
89. N Lambruschini, B Perez-Duenas, MA Vilaseca Clinical and nutritional evaluation of phenylketonuric patients on tetrahydrobiopterin monotherapy Mol Genet Metab 86 2005 54 60
90. FK Trefz, BK Burton, N Longo Efficacy of sapropterin dihydrochloride in increasing phenylalanine tolerance in children with phenylketonuria: a phase III, randomized, double-blind, placebo-controlled study J Pediatr 154 2009 700 707
91. B Fiege, N Blau Assessment of tetrahydrobiopterin (BH4)-responsiveness in phenylketonuria J Pediatr 150 2007 627 630
92. BK Burton, DK Grange, A Milanowski The response of patients with phenylketonuria and elevated serum phenylalanine to treatment with oral sapropterin dihydrochloride (6R-tetrahydrobiopterin): a phase II, multicentre, open-label, screening study J Inherit Metab Dis 30 2007 700 707
93. P Lee, EP Treacy, E Crombez Safety and efficacy of 22 weeks of treatment with sapropterin dihydrochloride in patients with phenylketonuria Am J Med Genet A 146 2008 2851 2859
94. R Gassio, MA Vilaseca, N Lambruschini, C Boix, ME Fuste, J Campistol Cognitive functions in patients with phenylketonuria in long-term treatment with tetrahydrobiopterin Mol Genet Metab 99 suppl 1 2010 75 78
95. R Matalon, K Michals-Matalon, G Bhatia Double blind placebo control trial of large neutral amino acids in treatment of PKU: effect on blood phenylalanine J Inherit Metab Dis 30 2007 153 158
96. S Schindeler, S Ghosh-Jerath, S Thompson The effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study Mol Genet Metab 91 2007 48 54
97. MJ MacDonald, GB D'Cunha A modern view of phenylalanine ammonia lyase Biochem Cell Biol 85 2007 273 282
98. CN Sarkissian, A Gamez, L Wang Preclinical evaluation of multiple species of PEGylated recombinant phenylalanine ammonia lyase for the treatment of phenylketonuria Proc Natl Acad Sci USA 52 2008 20894 20899
99. TS Kang, L Wang, CN Sarkissian, A Gamez, CR Scriver, RC Stevens Converting an injectable protein therapeutic into an oral form: phenylalanine ammonia lyase for phenylketonuria Mol Genet Metab 99 2010 4 9
100. A Rebuffat, CO Harding, Z Ding, B Thony Comparison of AAV pseudotype 1, 2, and 8 vectors administered by intramuscular injection in the treatment of murine phenylketonuria Hum Gene Ther 21 2010 463 477
101. SC Jung, JW Park, HJ Oh Protective effect of recombinant adeno-associated virus 2/8-mediated gene therapy from the maternal hyperphenylalaninemia in offsprings of a mouse model of phenylketonuria J Korean Med Sci 23 2008 877 883
102. Z Ding, CO Harding, A Rebuffat, L Elzaouk, JA Wolff, B Thony Correction of murine PKU following AAV-mediated intramuscular expression of a complete phenylalanine hydroxylating system Mol Ther 16 2008 673 681
103. CO Harding Progress toward cell-directed therapy for phenylketonuria Clin Genet 74 2008 97 104